Bisorcic

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Bisorcic ( ), also known as N 2 ,N 5 -diacetyl- L -ornithine, is a drug described as a hepatoprotective agent and "psychostimulant" which has been used in France in the treatment of asthenia. It is the N 2 ,N 5 -diacetylated derivative of the amino acid L -ornithine. Bisorcic was first described in the literature in 1973 in a German patent.

The was designated around 1975. The drug was marketed in France by Astyl-Gallier in 1987. It was provided in the form of 200 mg oral capsules and four capsules were taken daily.

L -Ornithine, as the combination drug L -ornithine L -aspartate (LOLA), has been used in the treatment of hepatic encephalopathy and cirrhosis and is likewise described as hepatoprotective. It is thought to work by participating in the urea cycle and lowering ammonia levels.

Bisorcic ( ), also known as N 2 ,N 5 -diacetyl- L -ornithine, is a drug described as a hepatoprotective agent and "psychostimulant" which has been used in France in the treatment of asthenia. It is the N 2 ,N 5 -diacetylated derivative of the amino acid L -ornithine. Bisorcic was first described in the literature in 1973 in a German patent.

The was designated around 1975. The drug was marketed in France by Astyl-Gallier in 1987. It was provided in the form of 200 mg oral capsules and four capsules were taken daily.

L -Ornithine, as the combination drug L -ornithine L -aspartate (LOLA), has been used in the treatment of hepatic encephalopathy and cirrhosis and is likewise described as hepatoprotective. It is thought to work by participating in the urea cycle and lowering ammonia levels.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1378203909 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

7 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.